Aptevo Therapeutics Correlations

APVO Stock

USD 3.82 0.23 6.41%

The current 90-days correlation between Aptevo Therapeutics and Cyclerion Therapeutics is 0.24 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptevo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptevo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Aptevo Therapeutics Correlation With Market

Significant diversification

The correlation between Aptevo Therapeutics and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aptevo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.

Moving together with Aptevo Stock

0.74	RNAC	Cartesian Therapeutics Earnings Call This Week	Pair Corr
0.68	STRO	Sutro Biopharma	Pair Corr
0.62	TERN	Terns Pharmaceuticals	Pair Corr
0.7	CTMX	CytomX Therapeutics	Pair Corr

Moving against Aptevo Stock

0.42	PFE	Pfizer Inc	Pair Corr
0.37	GANX	Gain Therapeutics	Pair Corr
0.36	PHGE	Biomx Inc	Pair Corr
0.34	OPT	Opthea	Pair Corr
0.33	CGTX	Cognition Therapeutics	Pair Corr
0.51	OBI	Ondine Biomedical	Pair Corr
0.5	SSNLF	Samsung Electronics	Pair Corr
0.44	EC	Ecopetrol SA ADR Sell-off Trend	Pair Corr
0.38	KO	Coca Cola	Pair Corr

Related Correlations Analysis

	KRON	CYCN	LRMR	ADXN	ACHL	NTRB	QNRX	LGVN	RNXT
KRON		0.05	0.09	0.07	0.11	0.44	-0.19	0.0	0.21	KRON
CYCN	0.05		0.42	-0.45	-0.27	-0.24	0.32	0.27	0.44	CYCN
LRMR	0.09	0.42		0.08	-0.65	-0.53	0.74	0.78	0.31	LRMR
ADXN	0.07	-0.45	0.08		-0.05	-0.02	0.11	0.14	-0.02	ADXN
ACHL	0.11	-0.27	-0.65	-0.05		0.63	-0.73	-0.63	-0.5	ACHL
NTRB	0.44	-0.24	-0.53	-0.02	0.63		-0.84	-0.72	-0.3	NTRB
QNRX	-0.19	0.32	0.74	0.11	-0.73	-0.84		0.9	0.45	QNRX
LGVN	0.0	0.27	0.78	0.14	-0.63	-0.72	0.9		0.44	LGVN
RNXT	0.21	0.44	0.31	-0.02	-0.5	-0.3	0.45	0.44		RNXT
	KRON	CYCN	LRMR	ADXN	ACHL	NTRB	QNRX	LGVN	RNXT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LGVN	+ 0.9	QNRX
LGVN	+ 0.78	LRMR
QNRX	+ 0.74	LRMR
NTRB	+ 0.63	ACHL
RNXT	+ 0.45	QNRX
NTRB	+ 0.44	KRON

High negative correlations

QNRX	- 0.84	NTRB
QNRX	- 0.73	ACHL
LGVN	- 0.72	NTRB
ACHL	- 0.65	LRMR
LGVN	- 0.63	ACHL
NTRB	- 0.53	LRMR

Risk-Adjusted Indicators

There is a big difference between Aptevo Stock performing well and Aptevo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aptevo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KRON	2.01	0.05	0.03	0.11	2.03	(3.23)	4.90	(3.00)	11.67
CYCN	13.55	4.04	0.37	(0.75)	8.51	(16.83)	35.71	(16.22)	326.74
LRMR	3.42	(1.03)	0.00	(0.54)	0.00	0.00	5.82	(6.53)	29.03
ADXN	4.23	0.19	0.03	12.08	5.33	(4.57)	9.57	(9.66)	30.24
ACHL	1.70	0.48	0.29	1.75	1.00	(3.31)	2.59	(2.80)	22.15
NTRB	6.96	1.27	0.18	0.88	6.13	(8.40)	17.09	(9.34)	54.72
QNRX	6.33	(0.83)	0.00	0.54	0.00	0.00	16.07	(10.53)	58.63
LGVN	3.16	(0.43)	0.00	(0.73)	0.00	0.00	6.70	(5.39)	17.94
RNXT	3.71	(0.14)	0.00	(0.17)	0.00	0.00	6.92	(8.04)	36.51

Aptevo Therapeutics Corporate Executives

Elected by the shareholders, the Aptevo Therapeutics' board of directors comprises two types of representatives: Aptevo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptevo. The board's role is to monitor Aptevo Therapeutics' management team and ensure that shareholders' interests are well served. Aptevo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptevo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Daphne Taylor	Senior CFO	Profile
Daphne CPA	Senior CFO	Profile
Jeffrey CA	Executive COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC